Interim report Q1 2019-01-01 – 2019-03-31
The Board and Chief Executive Officer of Cereno Scientific AB herewith present the interim report for the first quarter 2019.Summary of the interim report Three months (2019-01-01 – 2019-03-31) ● Net sales were 0 SEK (0 SEK). ● Loss after financial items was -5 333 633 SEK (-1 805 442 SEK). ● Loss per share was -0,28 SEK (-0,16 SEK) before dilution and -0,24 SEK* (-0,16 SEK) after dilution. ● Equity ratio was 42,0 % (88,9 %). Amounts in parentheses: Prior year comparative periodEquity ratio: Shareholders’ equity divided by total capitalEarnings